繁體中文
简体
HOME
ABOUT CHO
TEAM
Board of Directors
Scientific Advisory Board, SAB
PRODUCTS
R&D
PATENTS
NEWS
News Center
Media Report
CAREERS
CONTACT
中文版
News Center
Media Report
NEWS
Home
> News
Date:2022-04-29
Dr. Wu, the president of CHO Pharma, spoke about “The Distance between Academe and Industry” at 2022 NBRP (National Biotechnology Research Park) Demo Day
1.
Talk Notes
2.
Talk Slides
Press Release: Sparking Synergy! CHO Pharma and StemCyte Combine Antibody with Homogenous Glycan and Cell Therapy to Develop New Cancer Therapy.
“With the Key Technology, CHO Pharma Aims to be Global Design House of Glycan New Drug”, Money Weekly, March 24, 2022
Dr. Wu, the president of CHO Pharma, spoke about “The Distance between Academe and Industry” at 2022 NBRP (National Biotechnology Research Park) Demo Day
Press Release: Sparking Synergy! CHO Pharma and StemCyte Combine Antibody with Homogenous Glycan and Cell Therapy to Develop New Cancer Therapy.
“With the Key Technology, CHO Pharma Aims to be Global Design House of Glycan New Drug”, Money Weekly, March 24, 2022
